194 results on '"Elling D"'
Search Results
2. German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients
3. Efficacy and Patient Satisfaction of Breast Conserving Therapy for Central Breast Cancer by the B Technique
4. Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
5. Het kraken van een harde noot. Een vergelijking tussen Nederland en Engeland op het gebied van de gekozen burgemeester
6. Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
7. Poly(phenylenesulfide)-based coatings for carbon steel heat exchanger tubes in geothermal environments
8. Taxol – Ein Meilenstein in der Behandlung des Mammakarzinoms: Dosisintensiviertes und intervallverkürztes Studienkonzept für die Behandlung des 1- bis 3-nodalpositiven Mammakarzinoms
9. Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
10. Quality of care of VLBW-neonates: relationship between unit volume and outcome is different between metropolitan and rural regions
11. Quality of care of VLBW neonates: relationship between unit volume and outcome is different between metropolitan and rural regions
12. Gemcitabine, myocet and docetaxel for primary treatment of breast cancer: V269
13. A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy
14. Neoadjuvante Chemotherapie mit Gemcitabin als verlängerte Infusion, liposomalem Doxorubicin und Docetaxel: Ergebnisse einer Phase-I-Studie: V5–4
15. Adjuvant treatment of breast cancer patients with 1–3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study
16. Vinorelbine plus epirubicin (VE) and vinorelbine plus epirubicin sequential followed by paclitaxel (VE/T) as adjuvant chemotherapy in breast cancer patients with 1-3 positive lymph nodes: Phase II study.
17. Het Geldersche Zwijn. Over het creëren van identiteit in politieke opiniebladen in de Republiek in de periode 1781-1787
18. Intraductal component in invasive breast cancer: analysis of 250 resected surgical specimens
19. Ibandronate with or without Capecitabine in Elderly Patients with Early Breast Cancer – Aktueller Stand der Studie
20. Development of polymer concrete vaults for natural gas regulator stations
21. Microscopic inter-observer reliability of trained lab technicians diagnosing intestinal parasites
22. Lebensqualität nach transvaginal assistierter Cholezystektomie
23. Intense Dose-Dense Epirubicin (E), Paclitaxel (T), Cyclophosphamide (C) (Iddetc) is Highly Effective in Adjuvant Therapy of Node-Positive Breast Cancer Patients (Pts). an Analysis of the Gbg, Ago-B, and Noggo Study Groups
24. Abstract P1-14-05: Phase I/II Trial of primary chemotherapy with non-pegylated liposomal doxorubicin, paclitaxel and lapatinib in patients with HER2-positive, early stage breast cancer
25. S2-4: GAIN Study: A Phase III Trial To Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients with Node-Positive Primary Breast Cancer – 1st Interim Efficacy Analysis.
26. Gigantomastie in der Schwangerschaft – ein seltener Fall
27. P199 The 70-gene Mammaprint signature is an independent prognostic factor for elderly women with hormone receptor-positive, HER2-negative breast cancer
28. Comparative Study of Surgical Margins and Cosmetic Outcome in Lumpectomy versus Segmental Resection in Breast Cancer
29. Abstract P5-10-09: Comparison of the (Non-)Hematological Toxicity and Compliance of Different Anthracycline Containing Regimen with the Standard AC/EC in Elderly Patients with Primary Breast Cancer
30. Die B-Plastik – Eine retrospektive Studie zur Wertigkeit und Patientenzufriedenheit einer brusterhaltenden Therapie bei zentralem Sitz des Mammakarzinoms
31. Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
32. Minimalinvasive transvaginale Hemikolektomie rechts: Bericht über die erste komplexe NOS (Natural Orifice Surgery)Darmoperation in Hybridtechnik
33. Significant Changes in Circulating Plasma Levels of IGF1 and IGFBP3 after Conventional or Dose-Intensified Adjuvant Treatment of Breast Cancer Patients with one to three Positive Lymph Nodes
34. Gute Verträglichkeit von Epirubicin gefolgt von Paclitaxel und Trastuzumab bei der Behandlung von metastastiertem Mammakarzinom und Her2/neu-Überexpression (multizentrische Phase II Studie – NOGGO/AGO)
35. Toxicity in elderly breast cancer patients treated by a taxane based chemotherapy as adjuvant or neoadjuvant therapy for primary breast cancer
36. Association between breast cancer and estrogen receptor gene polymorphism PVU II
37. Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
38. Statusreport der ICE-Studie: Ibandronate mit/ohne Capecitabine bei älteren Patienten mit primären Mammakarzinom. Eine multizentrische prospektiv randomisierte Intergroup Studie der WSG, AGO, GBG und NOGGO
39. Non-pegylated liposomal doxorubicin and docetaxel as first-line treatment in metastatic breast cancer
40. Upregulation of HER-2/neu is independent of the menopausal status of primary breast cancer patients: Plasma results from a prospectively randomized trial comparing dose-intense chemotherapy with G-CSF support to 3-weekly chemotherapy for adjuvant therapy of nodal-positive (1–3 LN) breast cancer (German Adjuvant Study Group ASG)
41. Phase-II-Studie zur kombinierten Exemestan- und Goserelin-Adjuvanz-Therapie mit und ohne Tibolon bei prämenopausalen Frauen mit rezeptorpositivem und nodal-negativem Mammakarzinom: ADAGIO-Studie
42. Final analysis of weekly paclitaxel and weekly carboplatin (P) as first-line chemotherapy in 130 patients with advanced ovarian cancer (AOC)
43. Ibandronate with or without Capecitabine in Elderly Patients with Early Breast Cancer – Aktueller Stand der Studie
44. Safety and tolerability of adjuvant exemestane plus goserelin with or without tibolone in receptor-positive, node-negative primary breast cancer in premenopausal women: The final results of the randomized multicenter ADAGIO pilot study
45. Effect of adjuvant chemotherapy on circulating levels of ICAM, VCAM, VEGF and VEGFD in women with lymph node positive breast cancer.(NOGGO trial)
46. Confirmation of C9741 intergroup results in a prospectively randomized trial comparing dose-intense chemotherapy with G-CSF support to 3-weekly chemotherapy for adjuvant therapy of nodal-positive (1–3 LN) breast cancer: Longitudinal CA 27.29 results indicate higher decay of minimal residual disease in the dose-dense arm
47. A phase III randomised trial comparing the tolerability of dose-dense chemotherapy in older to that in younger breast cancer patients with four or more positive lymph nodes
48. Stellenwert der systemischen Chemotherapie beim Granulosazelltumor des Ovars: Eine Langzeitanalyse von 25 Patientinnen
49. 376 Primary chemotherapy with gemcitabine (G), myocet (M) and docetaxel (T): results of a phase I/II trial
50. Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.